Almac Partners with Merck KGaA and the MRC to Assess Markers of Response to Cetuximab Therapy

News   Apr 15, 2010

 
Almac Partners with Merck KGaA and the MRC to Assess Markers of Response to Cetuximab Therapy
 
 
 

RELATED ARTICLES

Sex Differences Revealed: Heart Failure Death Rates

News

Death from heart failure in men and women compared in a study of over 90 000 patients

READ MORE

Mouse Study Suggests That Dietary Fat, Not Carbs, Drives Obesity

News

A mouse study that made over 100,000 measurements of body weight and fat has concluded that the sole driver of obesity in mice is increased dietary fat content.

READ MORE

Testosterone Effective at Combating Cachexia in Cancer Patients

News

Many cancer patients suffer from a loss of body mass known as cachexia. A new study shows that the hormone testosterone is effective at combatting cachexia in cancer patients and improving quality of life.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy